A randomised placebo-controlled phase II trial of adjuvant avelumab with stage I-III Merkel Cell Carcinoma

  • Xu, Wen (Primary Chief Investigator (PCI))
  • Mar, Victoria (Chief Investigator (CI))
  • Paton, Elizabeth (Project Manager)
  • Williams, Narelle (Project Manager)

Project: Research

Project Details

Short titleMASC 03.18
AcronymI-MAT
StatusActive
Effective start/end date30/07/20 → 30/06/27